BackSigilon Therapeutics Overview

Sigilon Therapeutics Inventory

Sigilon Therapeutics's inventory is $250K.

Get informed when a big investor buys or sells

+ Follow
Inventory
$250000.00

Peer trimmed avg / median

Loading

Sigilon Therapeutics Inventory History

Loading

Sigilon Therapeutics vs. peers: Inventory Comparison

Loading

Sigilon Therapeutics Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sigilon Therapeutics (SGTX) FAQ

Sigilon Therapeutics (SGTX) currently reports a inventory of $250K as of June 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore Sigilon Therapeutics's inventory history and peer comparisons.

Sigilon Therapeutics's inventory changed from $0 to $250K (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sigilon Therapeutics reported $250K in inventory as of June 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $250K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sigilon Therapeutics, and consider following SGTX for alerts when major investors trade the stock.

Sigilon Therapeutics is classified in the Healthcare sector. On inventory, it currently shows $250K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SGTX with unrelated industries.